Alabama Pharmacy Board Defense Lawyer – Call Today – FDA Looking to Approve Lixisenatide Type 2 Diabetes Drug

1968_Graphic Image_Standard_060115Alabama Pharmacy Board Defense Lawyer – Call Today – FDA Looking to Approve Lixisenatide Type 2 Diabetes Drug – (866) 348-2889

The FDA is considering approval for Sanofi’s lixisenatide type 2 diabetes treatment.

Lixisenatide is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist. The brand name in the United States is still under consideration, but it approved as Lyxumia in Europe and other countries.

Sanofi originally submitted a New Drug Application (NDA) for lixisenatide in 2013, but the company pulled that application because the FDA was concerned about the cardiovascular safety of similar diabetes drugs.

Click Here to Read More

Alabama Pharmacist Defense Lawyer, Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.